vs

Side-by-side financial comparison of Peraso Inc. (PRSO) and VSEE HEALTH, INC. (VSEE). Click either name above to swap in a different company.

VSEE HEALTH, INC. is the larger business by last-quarter revenue ($3.9M vs $2.9M, roughly 1.4× Peraso Inc.). Peraso Inc. runs the higher net margin — -43.3% vs -200.0%, a 156.7% gap on every dollar of revenue. On growth, VSEE HEALTH, INC. posted the faster year-over-year revenue change (5.1% vs -22.0%). Over the past eight quarters, VSEE HEALTH, INC.'s revenue compounded faster (55.6% CAGR vs 1.0%).

Peraso Inc. is a semiconductor technology firm specializing in the design and production of high-performance millimeter wave (mmWave) integrated circuits and modules. It delivers 5G and next-generation wireless connectivity solutions for telecom infrastructure, industrial IoT, fixed wireless access and consumer electronics segments, serving customers across North America, Asia Pacific and European markets.

VSEE HEALTH, INC. is a US-based telehealth technology firm offering HIPAA-compliant virtual care platforms, remote consultation tools, and chronic disease management solutions. It primarily serves healthcare providers, enterprise clients and nonprofits across North America and select global markets.

PRSO vs VSEE — Head-to-Head

Bigger by revenue
VSEE
VSEE
1.4× larger
VSEE
$3.9M
$2.9M
PRSO
Growing faster (revenue YoY)
VSEE
VSEE
+27.1% gap
VSEE
5.1%
-22.0%
PRSO
Higher net margin
PRSO
PRSO
156.7% more per $
PRSO
-43.3%
-200.0%
VSEE
Faster 2-yr revenue CAGR
VSEE
VSEE
Annualised
VSEE
55.6%
1.0%
PRSO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PRSO
PRSO
VSEE
VSEE
Revenue
$2.9M
$3.9M
Net Profit
$-1.2M
$-7.9M
Gross Margin
52.2%
46.7%
Operating Margin
-44.6%
-87.6%
Net Margin
-43.3%
-200.0%
Revenue YoY
-22.0%
5.1%
Net Profit YoY
20.3%
-144.7%
EPS (diluted)
$-0.09
$-0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRSO
PRSO
VSEE
VSEE
Q4 25
$2.9M
$3.9M
Q3 25
$3.2M
$4.0M
Q2 25
$2.2M
$3.4M
Q1 25
$3.9M
$3.3M
Q4 24
$3.7M
$3.7M
Q3 24
$3.8M
$3.4M
Q2 24
$4.2M
$1.7M
Q1 24
$2.8M
$1.6M
Net Profit
PRSO
PRSO
VSEE
VSEE
Q4 25
$-1.2M
$-7.9M
Q3 25
$-1.2M
$-289.7K
Q2 25
$-1.8M
$-2.6M
Q1 25
$-471.0K
$-4.0M
Q4 24
$-1.6M
$-3.2M
Q3 24
$-2.7M
$-53.9M
Q2 24
$-4.4M
$-634.1K
Q1 24
$-2.0M
$62.8K
Gross Margin
PRSO
PRSO
VSEE
VSEE
Q4 25
52.2%
46.7%
Q3 25
56.2%
52.1%
Q2 25
48.3%
46.9%
Q1 25
69.3%
56.0%
Q4 24
56.3%
63.8%
Q3 24
47.0%
83.0%
Q2 24
55.5%
45.4%
Q1 24
46.4%
76.2%
Operating Margin
PRSO
PRSO
VSEE
VSEE
Q4 25
-44.6%
-87.6%
Q3 25
-36.8%
-51.7%
Q2 25
-80.0%
-66.5%
Q1 25
-13.3%
-55.1%
Q4 24
-44.3%
-81.1%
Q3 24
-70.3%
-1737.8%
Q2 24
-105.6%
-54.5%
Q1 24
-128.9%
6.4%
Net Margin
PRSO
PRSO
VSEE
VSEE
Q4 25
-43.3%
-200.0%
Q3 25
-37.4%
-7.3%
Q2 25
-82.4%
-77.1%
Q1 25
-12.2%
-119.2%
Q4 24
-42.4%
-85.9%
Q3 24
-70.6%
-1607.5%
Q2 24
-104.4%
-37.0%
Q1 24
-72.1%
3.9%
EPS (diluted)
PRSO
PRSO
VSEE
VSEE
Q4 25
$-0.09
$-0.31
Q3 25
$-0.17
$-0.02
Q2 25
$-0.31
$-0.16
Q1 25
$-0.10
$-0.24
Q4 24
$0.36
$-1.96
Q3 24
$-0.98
$-3.58
Q2 24
$-1.88
$-0.12
Q1 24
$-1.07
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRSO
PRSO
VSEE
VSEE
Cash + ST InvestmentsLiquidity on hand
$2.9M
$5.3M
Total DebtLower is stronger
$2.7M
Stockholders' EquityBook value
$4.6M
$5.5M
Total Assets
$6.1M
$22.4M
Debt / EquityLower = less leverage
0.50×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRSO
PRSO
VSEE
VSEE
Q4 25
$2.9M
$5.3M
Q3 25
$472.8K
Q2 25
$291.6K
Q1 25
$410.1K
Q4 24
$3.3M
$326.1K
Q3 24
$1.3M
$2.3M
Q2 24
$1.9M
$1.1M
Q1 24
$2.4M
$724
Total Debt
PRSO
PRSO
VSEE
VSEE
Q4 25
$2.7M
Q3 25
$3.4M
Q2 25
$3.0M
Q1 25
$2.6M
Q4 24
$1.9M
Q3 24
$1.9M
Q2 24
$2.4M
Q1 24
Stockholders' Equity
PRSO
PRSO
VSEE
VSEE
Q4 25
$4.6M
$5.5M
Q3 25
$3.6M
$-5.6M
Q2 25
$3.0M
$-5.7M
Q1 25
$3.6M
$-3.5M
Q4 24
$3.5M
$-18.5K
Q3 24
$2.0M
$933.1K
Q2 24
$3.6M
$53.1M
Q1 24
$6.7M
$-13.2M
Total Assets
PRSO
PRSO
VSEE
VSEE
Q4 25
$6.1M
$22.4M
Q3 25
$6.2M
$18.7M
Q2 25
$5.5M
$18.2M
Q1 25
$6.7M
$19.4M
Q4 24
$7.2M
$20.0M
Q3 24
$7.2M
$22.3M
Q2 24
$9.8M
$78.6M
Q1 24
$11.5M
$1.4M
Debt / Equity
PRSO
PRSO
VSEE
VSEE
Q4 25
0.50×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
2.08×
Q2 24
0.05×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRSO
PRSO
VSEE
VSEE
Operating Cash FlowLast quarter
$-1.1M
$-1.9M
Free Cash FlowOCF − Capex
$-1.9M
FCF MarginFCF / Revenue
-49.2%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-3.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRSO
PRSO
VSEE
VSEE
Q4 25
$-1.1M
$-1.9M
Q3 25
$-1.5M
$-754.5K
Q2 25
$-2.0M
$-324.6K
Q1 25
$-966.0K
$-440.5K
Q4 24
$-687.0K
$-3.0M
Q3 24
$-683.0K
$-221.0K
Q2 24
$-659.0K
$-3.2M
Q1 24
$-2.5M
$579.3K
Free Cash Flow
PRSO
PRSO
VSEE
VSEE
Q4 25
$-1.9M
Q3 25
$-1.6M
$-761.8K
Q2 25
$-328.2K
Q1 25
$-452.4K
Q4 24
$-3.0M
Q3 24
$-226.0K
Q2 24
$-3.2M
Q1 24
$570.5K
FCF Margin
PRSO
PRSO
VSEE
VSEE
Q4 25
-49.2%
Q3 25
-48.9%
-19.1%
Q2 25
-9.7%
Q1 25
-13.6%
Q4 24
-79.8%
Q3 24
-6.7%
Q2 24
-187.6%
Q1 24
35.2%
Capex Intensity
PRSO
PRSO
VSEE
VSEE
Q4 25
0.2%
Q3 25
1.1%
0.2%
Q2 25
0.1%
Q1 25
0.4%
Q4 24
0.1%
Q3 24
0.1%
Q2 24
2.1%
Q1 24
0.5%
Cash Conversion
PRSO
PRSO
VSEE
VSEE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
9.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRSO
PRSO

Products$2.8M96%
Other$105.0K4%

VSEE
VSEE

Professional Services And Other Fees$3.1M79%
Other$823.2K21%

Related Comparisons